OPX has developed propriety technology to produce economic, bio-based chemicals. Its technology platform enables faster, more efficient development of bioprocesses using a variety of feedstocks.
WCP invested in a growth capital round for OPX in 2011. In 2015, Cargill acquired OPX’s proprietary fermentation-based processes and systems.
Status: Realized
Visit Website
WCP invested in a growth capital round for OPX in 2011. In 2015, Cargill acquired OPX’s proprietary fermentation-based processes and systems.
Status: Realized
Visit Website
Investors 1
| Date | Name | Website |
| - | Encourage ... | encouragec... |
Mentions in press and media 1
| Date | Title | Description |
| 28.09.2015 | Synthetic Biology Is Not Just Good, It’s Good For You | Emily Leproust Contributor Emily Leproust is CEO of Twist Bioscience. More posts by this contributor Beyond The $1K Genome: DNA ‘Writing’ Comes Next Synthetic biology (synbio for short) is a term that circulates freely through the tech worl... |